About US
Contact us
-
US FTC ramps up patent crusade with investigation into Teva's inhaler IP: reportWhile certain other drugmakers have relented in the face of the U.S. Federal Trade Commission’s (FTC’s) assault on alleged “junk” patents in the FDA’s Orange Book, Teva has largely stood its ground.2024/6/20
-
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myelomaIn a major win for Johnson & Johnson and Legend Biotech, their star CAR-T therapy Carvykti showed it can prolong the lives of patients with previously treated multiple myeloma. J&J and Legend2024/6/18
-
After Gilead and J&J lawsuits, distributor Safe Chain sees its owners charged in criminal indictmentIn yet another legal development surrounding counterfeit HIVdrugs, a Florida court has handed down an indictment for the owners of a wholesale distributor that allegedly bought and redistributed $902024/6/18
-
Sun Pharma brightens up Ilumya promos with psoriasis campaign encouraging self-loveWhile many campaigns for plaque psoriasis treatments focus on erasing the external effects of the condition, Sun Pharma’s latest Ilumya push is emphasizing the importance of looking inward, too. The2024/6/13
-
Lilly touts fibrosis win as it pads case for tirzepatide in MASHBack in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease. Now, the company is2024/6/13
-
FDA cracks down on China's Hengrui in scathing manufacturing write-upWhen the FDA comes knocking at your drug manufacturing facility, it’s best to play along. Unfortunately for Jiangsu Hengrui Pharmaceuticals, the company’s refusal to do so has resulted in a scathing2024/6/11
-
Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle PharmaIn recent months, Vanda Pharmaceuticals has been busy working to grow its commercial presence through itsacquisitionof Johnson & Johnson's Ponvory and itsrecent bipolar disorder approvalfor Fanap2024/6/11
-
Eli Lilly tipped to leapfrog Eisai, Biogen and take control of $13B Alzheimer's marketEisai and Biogen’s reign at the top of the Alzheimer’s disease market may be short-lived. While Leqembi is the only game in town today, Bloomberg Intelligence (BI) analysts expect Eli Lilly to come f2024/6/6
-
France's Orano Med debuts radiotherapy manufacturing plant near IndianapolisAmid a nuclear medicine boom, France’s Orano Med has chosen the U.S. to establish a manufacturing plant as it progresses on its radiopharma journey. Orano Med—which is working on targeted alpha thera2024/6/6
-
CDC recommends antibiotic doxycycline to protect against STIs after potential exposureDoxycycline, an antibiotic widely used to combat acne, malaria and Lyme disease, has beenrecommendedby the CDC for use in the United States by gay and bisexual men and transgender women after having2024/6/4